We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.58%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.12B
AUM Growth
-$199M
(-3.7%)
Cap. Flow
-$200M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
24.54%
Holding
885
New
102
Increased
287
Reduced
309
Closed
94
Avg Time Held
1.8
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$25.9M |
| 2 |
Citizens Financial Group
CFG
|
+$23.8M |
| 3 |
EOG Resources
EOG
|
+$23.7M |
| 4 |
Independent Bank Group, Inc.
IBTX
|
+$18.4M |
| 5 |
Acuity Brands
AYI
|
+$17.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAV
B/E Aerospace Inc
BEAV
|
+$48.6M |
| 2 |
Ventas
VTR
|
+$42.2M |
| 3 |
Centene
CNC
|
+$38.9M |
| 4 |
Manhattan Associates
MANH
|
+$30.4M |
| 5 |
Salesforce
CRM
|
+$24.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.09% |
| 2 | Financials | 14.79% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 14.11% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Snap-on
SNA
$18.9B
| $835K | 0.02% |
4,878
+607
| +14% | +$98.7K |
2015 Q2
6 quarters
|
|
352
Eagle Materials
EXP
$5.23B
| $834K | 0.02% |
+8,464
| New | +$760K |
2016 Q4
0 quarters
|
|
353
DELISTED
Echo Global Logistics, Inc.
ECHO
| $828K | 0.02% |
+33,063
| New | +$805K |
2016 Q4
0 quarters
|
|
354
Vanguard Morningstar Growth ETF
VUG
$232B
| $823K | 0.02% |
44,310
+5,184
| +13% | +$95.9K |
2015 Q4
4 quarters
|
|
355
Canadian Pacific Kansas City
CP
$76.4B
| $812K | 0.02% |
28,430
-870
| -3% | -$25.7K |
2013 Q4
12 quarters
|
|
356
Sasol
SSL
$10.2B
| $811K | 0.02% |
28,376
-1,272
| -4% | -$35K |
2014 Q2
10 quarters
|
|
|
TWO
357
DELISTED
Two Harbors Investment
TWO
| $800K | 0.02% |
11,473
+1,800
| +19% | +$123K |
2016 Q1
3 quarters
|
|
358
Hercules Capital
HTGC
$3.12B
| $798K | 0.02% |
56,558
+12,213
| +28% | +$166K |
2016 Q3
1 quarter
|
|
359
Lowe's Companies
LOW
$110B
| $798K | 0.02% |
11,225
+58
| +0.5% | +$4.1K |
2013 Q2
14 quarters
|
|
360
Phillips 66
PSX
$115B
| $797K | 0.02% |
9,224
-606
| -6% | -$50.4K |
2013 Q2
14 quarters
|
|
361
AXIS Capital Holdings Ltd Series E
AXS.PRE
$384M
| $794K | 0.02% |
+36,680
| New | +$810K |
2016 Q4
0 quarters
|
|
362
Mercury Systems
MRCY
$4.65B
| $788K | 0.02% |
+26,075
| New | +$741K |
2016 Q4
0 quarters
|
|
|
BSTC
363
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $786K | 0.02% |
14,113
+56
| +0.4% | +$2.69K |
2014 Q1
11 quarters
|
|
364
Insulet
PODD
$9.62B
| $785K | 0.02% |
20,825
+622
| +3% | +$23.2K |
2013 Q2
14 quarters
|
|
365
Aflac
AFL
$59.2B
| $780K | 0.02% |
22,410
+946
| +4% | +$33.3K |
2013 Q4
12 quarters
|
|
366
CSX Corp
CSX
$90.2B
| $780K | 0.02% |
65,103
+41,112
| +171% | +$461K |
2013 Q4
12 quarters
|
|
367
Duke Energy
DUK
$92.7B
| $778K | 0.02% |
10,028
+820
| +9% | +$62.8K |
2013 Q2
14 quarters
|
|
368
Omega Healthcare
OHI
$13.8B
| $776K | 0.02% |
24,821
+2,623
| +12% | +$81K |
2015 Q4
4 quarters
|
|
369
Weyerhaeuser
WY
$14B
| $775K | 0.02% |
25,758
-418
| -2% | -$12.9K |
2014 Q1
11 quarters
|
|
370
Annaly Capital Management
NLY
$13.9B
| $773K | 0.02% |
19,390
+1,454
| +8% | +$59.1K |
2016 Q2
2 quarters
|
|
|
IMPV
371
DELISTED
Imperva, Inc.
IMPV
| $772K | 0.02% |
20,110
+422
| +2% | +$17.1K |
2014 Q4
8 quarters
|
|
372
Parker-Hannifin
PH
$121B
| $761K | 0.01% |
5,435
+347
| +7% | +$46.1K |
2015 Q2
6 quarters
|
|
373
Dycom Industries
DY
$7.77B
| $751K | 0.01% |
9,359
+741
| +9% | +$60K |
2016 Q2
2 quarters
|
|
374
DELISTED
Hess
HES
| $742K | 0.01% |
11,911
+66
| +0.6% | +$3.61K |
2016 Q1
3 quarters
|
|
375
Alerian MLP ETF
AMLP
$12.5B
| $735K | 0.01% |
11,664
+822
| +8% | +$50.8K |
2013 Q2
14 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, Geneva Advisors held 885 positions worth $5.12B, down 3.7% from $5.32B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Geneva Advisors withdrew a net $200M in Q4 2016, closing 94 positions and reducing 309 holdings. Its most notable exit was Ventas, an estimated $42.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
Against the trend, Geneva Advisors opened a new position in Citizens Financial Group worth $28M.
- Geneva Advisors's largest Q4 2016 buy was Citizens Financial Group: 786,703 shares worth $28M.
- Geneva Advisors added most to Celgene Corp in Q4 2016, an estimated $25.9M increase.
- Geneva Advisors's biggest Q4 2016 reduction was B/E Aerospace Inc, cutting an estimated $48.6M.
- Geneva Advisors fully exited Ventas in Q4 2016, selling an estimated $42.2M.
- Geneva Advisors's ten largest holdings make up 25% of its $5.12B portfolio in Q4 2016.
- Geneva Advisors opened 102 new positions and closed 94 in Q4 2016.
- Geneva Advisors's portfolio value fell 3.7% quarter-over-quarter to $5.12B.
Based on Geneva Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.